HIV Citations List: November 2024
Literature Citations
1. Synthesis, Crystal Structure, and Antiviral Evaluation of New Imidazopyridine-Schiff Base Derivatives: in vitro and in silico Anti-HIV Studies. Azzouzi, M., A.A. Ouchaoui, O. Azougagh, S.E. El Hadad, M. Abou-Salama, A. Oussaid, C. Pannecouque, and T. Rohand. RSC Advances, 2024. 14(50): p. 36902-36918. PMID[39569129]. PMCID[PMC11574953].
[PubMed]. HIV_11_2024.
2. A Dual-Purpose Humanized Mouse Model for Testing Antiviral Strategies against Both SIV and HIV. Barnett, E., S. Kaginkar, K. Schmitt, L. Remling-Mulder, and R. Akkina. Frontiers in Immunology, 2024. 15: p. 1491481. PMID[39559349]. PMCID[PMC11570277].
[PubMed]. HIV_11_2024.
3. Pro-Inflammatory Macrophages Suppress HIV Replication in Humanized Mice and ex vivo Co-Cultures. Baroncini, L., C.K.S. Muller, N.P. Kadzioch, R. Wolfensberger, D. Russenberger, S. Bredl, T. Mlambo, and R.F. Speck. Frontiers in Immunology, 2024. 15: p. 1439328. PMID[39575258]. PMCID[PMC11578737].
[PubMed]. HIV_11_2024.
4. Assessment of the Toxicity of Different Antiretroviral Drugs and Their Combinations on Sertoli and Leydig Cells. Baysal, M., A.B. Karaduman, B. Korkut Çelikateş, Ö. Atlı-Eklioğlu, and S. Ilgın. Drug and Chemical Toxicology, 2024. 47(6): p. 1100-1108. PMID[38647040].
[PubMed]. HIV_11_2024.
5. A New Class of Capsid-Targeting Inhibitors That Specifically Block HIV-1 Nuclear Import. Boulay, A., E. Quevarec, I. Malet, G. Nicastro, C. Chamontin, S. Perrin, C. Henriquet, M. Pugnière, V. Courgnaud, M. Blaise, A.G. Marcelin, I.A. Taylor, L. Chaloin, and N.J. Arhel. EMBO Molecular Medicine, 2024. 16(11): p. 2918-2945. PMID[39358603]. PMCID[PMC11555092].
[PubMed]. HIV_11_2024.
6. A Novel HIV Triple Broadly Neutralizing Antibody (bNAb) Combination-Based Passive Immunization of Infant Rhesus Macaques Achieves Durable Protective Plasma Neutralization Levels and Mediates Anti-Viral Effector Functions. Dankwa, S., C. Kosman, M. Dennis, E.E. Giorgi, K. Vuong, I. Pahountis, A. Garza, C. Binuya, J. McCarthy, B.T. Mayer, J.T. Ngo, C.A. Enemuo, D.G. Carnathan, S. Stanfield-Oakley, S.J. Berendam, C. Weinbaum, K. Engelman, D.M. Magnani, C. Chan, G. Ferrari, G. Silvestri, R.R. Amara, A. Chahroudi, S.R. Permar, G.G. Fouda, and R. Goswami. PLOS One, 2024. 19(11): p. e0312411. PMID[39527587]. PMCID[PMC11554116].
[PubMed]. HIV_11_2024.
7. Modeling Virus-Stimulated Proliferation of CD4(+) T-Cell, Cell-to-Cell Transmission and Viral Loss in HIV Infection Dynamics. Deng, J., H. Shu, L. Wang, and X. Zou. Mathematical Biosciences, 2024. 377: p. 109302. PMID[39276975].
[PubMed]. HIV_11_2024.
8. The Structural and Mechanistic Bases for the Viral Resistance to Allosteric HIV-1 Integrase Inhibitor Pirmitegravir. Dinh, T., Z. Tber, J.S. Rey, S. Mengshetti, A.S. Annamalai, R. Haney, L. Briganti, F. Amblard, J.R. Fuchs, P. Cherepanov, K. Kim, R.F. Schinazi, J.R. Perilla, B. Kim, and M. Kvaratskhelia. mBio, 2024. 15(11): p. e0046524. PMID[39404354]. PMCID[PMC11559089].
[PubMed]. HIV_11_2024.
9. Investigating the Effect of GLU283 Protonation State on the Conformational Heterogeneity of CCR5 by Molecular Dynamics Simulations. Dogan, B. and S. Durdağı. Journal of Chemical Information and Modeling, 2024. 64(21): p. 8283-8298. PMID[39435878].
[PubMed]. HIV_11_2024.
10. Croton Oligandrus Pierre & Hutch (Euphorbiaceae) Extracts and Isolated Compounds Reverse HIV-1 Latency. Emade Nkwelle, C., S.B. Babiaka, C.S. Metuge, K. Liang, U. Stephens, S.N. Esemu, D.S. Zuzga, K. Shuda McGuire, L.J. Montaner, R.N. Ndip, I. Tietjen, and F. Ntie-Kang. Journal of Experimental Pharmacology, 2024. 16: p. 413-425. PMID[39582514]. PMCID[PMC11585272].
[PubMed]. HIV_11_2024.
11. A Selective HIV-1 RNA G-Quadruplex-Targeting L-Aptamer-D-Antisense Conjugate Inhibits HIV-1 Minus Strand Transfer. Feng, H. and C.K. Kwok. Chemical Communications (Camb), 2024. 60(92): p. 13558-13561. PMID[39474771].
[PubMed]. HIV_11_2024.
12. Bictegravir Alters Glucose Tolerance in vivo and Causes Hepatic Mitochondrial Dysfunction. García-Martínez, P., L. Gisbert-Ferrándiz, Á. Álvarez, J.V. Esplugues, and A. Blas-García. Antiviral Research, 2024. 231: p. 106020. PMID[39413881].
[PubMed]. HIV_11_2024.
13. Characterization of Novel HIV Fusion-Inhibitory Lipopeptides with the M-T Hook Structure. Geng, X., X. Ding, Y. Zhu, H. Chong, and Y. He. Microbes and Infection, 2024. 26(8): p. 105366. PMID[38777106].
[PubMed]. HIV_11_2024.
14. HIV-1 N-Myristoylation-Dependent Hijacking of Late Endosomes/Lysosomes to Drive Gag Assembly in Macrophages. Guajardo-Contreras, G.I., A.L. Abdalla, A. Chen, M. Niu, E. Beauchamp, L.G. Berthiaume, A.W. Cochrane, and A.J. Mouland. Journal of Cell Science, 2024. 137(22). PMID[39439384]. PMCID[PMC11607699].
[PubMed]. HIV_11_2024.
15. Production and Characterization of Novel Anti-HIV Fc-Fusion Proteins in Plant-Based Systems: Nicotiana Benthamiana & Tobacco BY-2 Cell Suspension. Gutierrez-Valdes, N., F. Cunyat, J. Balieu, M.L. Walet-Balieu, M.J. Paul, J. de Groot, A. Blanco-Perera, J. Carrillo, P. Lerouge, M.J. Seters, J.J. Joensuu, M. Bardor, J. Ma, J. Blanco, and A. Ritala. Nature Biotechnology, 2024. 83: p. 142-154. PMID[39142626].
[PubMed]. HIV_11_2024.
16. IFI27 Inhibits HIV-1 Replication by Degrading Gag Protein through the Ubiquitin-Proteasome Pathway. He, W.Q., W. Pang, N. Li, A.Q. Li, Y.H. Li, Y. Lu, F. Shen, R. Xin, T.Z. Song, R.R. Tian, L.M. Yang, and Y.T. Zheng. Journal of Virology, 2024. 98(11): p. e0135624. PMID[39475279]. PMCID[PMC11575308].
[PubMed]. HIV_11_2024.
17. Expanding the Solvent/Protein Region Occupation of the Non-Nucleoside Reverse Transcriptase Inhibitor Binding Pocket for Improved Broad-Spectrum Anti-HIV-1 Efficacy: From Rigid Phenyl-Diarylpyrimidines to Flexible Hydrophilic Piperidine-Diarylpyrimidines. Huang, W.J., C. Pannecouque, E. De Clercq, A. Corona, S. Maloccu, E. Tramontano, S. Wang, and F.E. Chen. Journal of Medicinal Chemistry, 2024. 67(21): p. 19889-19904. PMID[39498544].
[PubMed]. HIV_11_2024.
18. Discovery of Potent HIV-1 NNRTIs by CuAAC Click-Chemistry-Based Miniaturized Synthesis, Rapid Screening and Structure Optimization. Jing, L., G. Wu, F. Zhao, X. Jiang, N. Liu, D. Feng, Y. Sun, T. Zhang, E. De Clercq, C. Pannecouque, D. Kang, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2024. 277: p. 116772. PMID[39167895].
[PubMed]. HIV_11_2024.
19. Evaluation of Anti-HIV-1 (Retroviridae: Orthoretrovirinae: Lentivirus: Human Immunodeficiency Virus Type 1) Activity of 6HP and 3TC in Vitro Using MT-4 Cell Line Variants with Different Replicative Activity. Kalnina, L.B., L.M. Selimova, and D.N. Nosik. Vopr Virusol, 2024. 69(5): p. 441-448. PMID[39527766].
[PubMed]. HIV_11_2024.
20. Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Lee, D., L. Niu, S. Ding, H. Zhu, W.D. Tolbert, H. Medjahed, G. Beaudoin-Bussières, C. Abrams, A. Finzi, M. Pazgier, and A.B. Smith, 3rd. ACS Medicinal Chemistry Letters, 2024. 15(11): p. 1961-1969. PMID[39563795]. PMCID[PMC11571091].
[PubMed]. HIV_11_2024.
21. Ginkgolic Acid Regulates Myogenic Development by Influencing the Proliferation and Differentiation of C2C12 Myoblast Cells. Liu, H. and H. Joung. Molecular Medicine Reports, 2024. 30(5). PMID[39301652]. PMCID[PMC11413845].
[PubMed]. HIV_11_2024.
22. HIV-1 Reverse Transcriptase Error Rates and Transcriptional Thresholds Based on Single-Strand Consensus Sequencing of Target RNA Derived from in vitro-Transcription and HIV-Infected Cells. Martínez Del Río, J., E. Frutos-Beltrán, A. Sebastián-Martín, F. Lasala, K. Yasukawa, R. Delgado, and L. Menéndez-Arias. Journal of Molecular Biology, 2024. 436(22): p. 168815. PMID[39384034].
[PubMed]. HIV_11_2024.
23. Epitranscriptomic m(6)A Modifications During Reactivation of HIV-1 Latency in CD4(+) T Cells. Mishra, T., S. Phillips, Y. Zhao, B. Wilms, C. He, and L. Wu. mBio, 2024. 15(11): p. e0221424. PMID[39373537]. PMCID[PMC11559067].
[PubMed]. HIV_11_2024.
24. NSC95397 Is a Novel HIV-1 Latency-Reversing Agent. Nichols Doyle, R., V. Yang, Y.I. Kayode, R. Damoiseaux, H.E. Taylor, and O.I. Fregoso. Viruses, 2024. 16(11). PMID[39599897]. PMCID[PMC11599149].
[PubMed]. HIV_11_2024.
25. Cyclophilin A Facilitates HIV-1 Integration. Padron, A., R. Dwivedi, R. Chakraborty, P. Prakash, K. Kim, J. Shi, J. Ahn, J. Pandhare, J. Luban, C. Aiken, M. Balasubramaniam, and C. Dash. Journal of Virology, 2024. 98(11): p. e0094724. PMID[39480090]. PMCID[PMC11575316].
[PubMed]. HIV_11_2024.
26. Ectopic USP15 Expression Inhibits HIV-1 Transcription Involving Changes in YY1 Deubiquitination and Stability. Rezaei, S., K.A. Timani, Y. Liu, and J.J. He. Frontiers in Cellular and Infection Microbiology, 2024. 14: p. 1371655. PMID[39624264]. PMCID[PMC11609158].
[PubMed]. HIV_11_2024.
27. HIV-1 Budding Requires Cortical Actin Disassembly by the Oxidoreductase MICAL1. Serrano, T., N. Casartelli, F. Ghasemi, H. Wioland, F. Cuvelier, A. Salles, M. Moya-Nilges, L. Welker, S. Bernacchi, M. Ruff, A. Jégou, G. Romet-Lemonne, O. Schwartz, S. Frémont, and A. Echard. Proceedings of the National Academy of Sciences of the United States of America, 2024. 121(48): p. e2407835121. PMID[39556735].
[PubMed]. HIV_11_2024.
28. Invention of VH-937, a Potent HIV-1 Maturation Inhibitor with the Potential for Infrequent Oral Dosing in Humans. Sit, S.Y., Y. Chen, J. Chen, B.L. Venables, J.J. Swidorski, L. Xu, N. Sin, R.A. Hartz, Z. Lin, S. Zhang, Z. Li, D.R. Wu, P. Li, J. Kempson, X. Hou, Y. Shanmugam, D. Parker, S. Jenkins, J. Simmermacher, P. Falk, B. McAuliffe, M. Cockett, U. Hanumegowda, I. Dicker, M. Krystal, N.A. Meanwell, and A. Regueiro-Ren. ACS Medicinal Chemistry Letters, 2024. 15(11): p. 1997-2004. PMID[39563829]. PMCID[PMC11571082].
[PubMed]. HIV_11_2024.
29. Optimization of Dolutegravir and Epigallocatechin Gallate Loaded Nanoemulsion for Enhanced Oral Delivery in NeuroAIDS Management. Tyagi, S., S.Y. Gaikwad, M. Chandane-Tak, A. Mukherjee, and S. Kumar. Journal of Drug Delivery Science and Technology, 2024. 101. ISI[001338985600001].
[WOS]. HIV_11_2024.
30. Development and Characterization of High-Affinity Aptamers for HIV Protease Detection. Valadés-Alcaraz, A., R. Reinosa, M. González-Hevilla, C. Medina-Sánchez, and Á. Holguín. Heliyon, 2024. 10(22): p. e38234. PMID[39624307]. PMCID[PMC11609250].
[PubMed]. HIV_11_2024.
31. Distinguishable Topology of the Task-Evoked Functional Genome Networks in HIV-1 Reservoirs. Wiśniewski, J., K. Więcek, H. Ali, K. Pyrc, A. Kula-Păcurar, M. Wagner, and H.C. Chen. iScience, 2024. 27(11): p. 111222. PMID[39559761]. PMCID[PMC11570469].
[PubMed]. HIV_11_2024.
32. "Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency. Xu, S., S. Wang, Y. Zhou, N. Foley, L. Sun, L. Walsham, K. Tang, D. Shi, X. Shi, Z. Zhang, X. Jiang, S. Gao, X. Liu, C. Pannecouque, D.C. Goldstone, A. Dick, and P. Zhan. Journal of Medicinal Chemistry, 2024. 67(21): p. 19057-19076. PMID[39418501].
[PubMed]. HIV_11_2024.
33. First Principles Energetic Span Analysis of the Activity of Transition Metal Catalysts for N2O Decomposition: The Reversal of Descriptor Roles in the Presence of NO. Yadav, G. and A. Khetan. Catalysis Today, 2024. 441. ISI[001346407500001].
[WOS]. HIV_11_2024.
34. Bambusicolous Mycopathogens in China with an Update on Taxonomic Diversity, Novel Species, Pathogenicity, and New Insights. Yang, C.L., X.L. Xu, Q. Zeng, L.J. Liu, F. Liu, Y. Deng, F.H. Wang, Q.R. Sun, R. Jeewon, K.D. Hyde, R.S. Jayawardena, E.H.S. McKenzie, D.N. Wanasinghe, Y.G. Liu, Q.G. Xiao, S. Han, H. Yang, S.J. Li, L. Liu, and J.L. Xie. Mycosphere, 2024. 15(1): p. 4788-4918. ISI[001340127800001].
[WOS]. HIV_11_2024.
35. Discovery of 2,4,6-Trisubstituted Pyrimidine Derivatives as Novel Potent HIV-1 NNRTIs by Exploiting the Tolerant Region II of the NNIBP. Zhou, Z., Y. Sun, Y. Qin, N. Wang, F. Zhao, Z. Wang, E. Clercq, C. Pannecouque, P. Zhan, D. Kang, and X. Liu. European Journal of Medicinal Chemistry, 2024. 277: p. 116708. PMID[39094273].
[PubMed]. HIV_11_2024.
Patent Citations
This month, no relevant HIV patents were identified.